Predicting the unpredictable: Autoantibody profile as parameter to foretell individual responses to infliximab treatment?

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1160-1161

  Schon M P ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; INFLIXIMAB; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 23; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; CONTROLLED CLINICAL TRIAL (TOPIC); DNA REPAIR; DRUG TARGETING; HUMAN; IMMUNOTHERAPY; KERATINOCYTE; NOTE; PREDICTION; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; TREATMENT RESPONSE;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; DERMATOLOGIC AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; MALE; PSORIASIS;

EID: 82255186737     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10677.x     Document Type: Note

References (10)

1. Williams VL, Cohen PR,. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 2011; 50: 619-25.
2. Kerbleski JF, Gottieb AB,. Dermatological complications and safety of anti-TNF treatments. Gut 2009; 58: 1033-9.
3. Bout-Tabaku S, Rivas-Chacon R, Restrepo R,. Systemic lupus erythematosus in a patient with etanercept for polyarticular juvenile rheumatoid arthritis. J Rheumatol 2007; 34: 2503-4. (Pubitemid 350230683)
4. D'Auria F, Rovere-Querini P, Giazzon M, et al. Accumulation of plasma nucleosomes upon treatment with anti-tumor necrosis factor-alpha antibodies. J Intern Med 2004; 255: 409-18. (Pubitemid 38315283)
5. Faurschou A, Gniadecki R, Wulf HC,. Infliximab inhibits DNA repair in ultraviolet B-irradiated premalignant keratinocytes. Exp Dermatol 2008; 17: 933-8.
6. Ferraccioli G, Mecchia F, Di Poi E, Fabris M,. Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional therapy: direct and indirect evidence for a possible association with infections. Ann Rheum Dis 2002; 62: 358-61. (Pubitemid 34257750)
7. Via CS, Shustov A, Rus V, et al. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol 2001; 167: 6821-6. (Pubitemid 33144173)
8. Costa MF, Said NR, Zimmermann B,. Drug induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 2008; 37: 381-7. (Pubitemid 351734520)
9. Hoffmann JHO, Hartmann M, Enk AH, Hadaschik EN,. Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction. Br J Dermatol 2011; 165: 1355-58.
10. Pink AE, Fonia A, Allen MH, et al. Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 2010; 162: 780-5.